CAUTREELS WERNER 4
4 · Traws Pharma, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
CAUTREELS WERNER
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$0.01/sh+96,348$963→ 104,348 total - Exercise/Conversion
Pre-Funded Warrant (right to buy)
2025-02-18−96,348→ 0 totalExercise: $0.01→ Common Stock (96,348 underlying)
Footnotes (3)
- [F1]The Common Stock was acquired by way of an exercise of Pre-Funded Warrants at an exercise price of $0.01 per Pre-Funded Warrant. The Pre-Funded warrants were acquired as part of Class B Units, with each Class B unit consisting of one Pre-Funded Warrant and one Series A Warrant, at a purchase price of $5.093 per Class B Unit.
- [F2]The Pre-Funded Warrants became exercisable upon stockholder approval on February 17, 2025.
- [F3]The Pre-Funded Warrants do not expire.